This event was broadcast live on Tuesday, July 26.
Watch the full replay at your convenience by registering on the form to the right.
Emerging life sciences companies struggle with complex product registrations and Health Authority (HA) interactions. The process for product registrations is complicated by compliance variations across geographies. A recent 2022 World Class RIM study by Gens & Associates showed that 41% of small and very small life sciences companies consider Submission Planning and Tracking, HA Commitments and Interactions among the top 5 technology priorities.
Watch our live-streamed webinar with industry experts who shared how technology initiatives are helping life sciences companies transform their product registration process across multiple geographies.
During the webinar, our panelists discussed their experience working with life sciences companies of all sizes, and covered:
- Performance Challenges at Emerging LS Companies
- Current RIM Landscape
- Modernizing Product Registrations with Technology
- Live Q&A
Independent Regulatory Affairs Expert
Gens & Associates Partner
V. “Bala” Balasubramanian
Life Sciences Practice Leader
RIM Reference Model Lead
Director of Life Sciences Business Development
Audience for the Webinar: Life Sciences and medical devices industry executives (VPs, Directors, etc) across all functions that interact with the regulatory lifecycle:
- Research & Development (R&D)
- Regulatory Affairs & Operations
- Manufacturing & Quality
- IT / Operations
Orion has been serving the Life Sciences industry with business solutions for over a decade.
Find out about Orion’s Regulatory Affairs Lifecycle Management Platform (ReALM®).
Learn more about our expertise here.